Free Research Reports on DNDN, INO, MCP and PPHM Issued by the Bedford Report

NEW YORK, NY -- (Marketwire) -- 01/08/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Dendreon Corporation (NASDAQ: DNDN) shares have rallied 18 percent in the past month. The company recently reported that it expects product revenue of Provenge, their prostate cancer therapy, to total approximately $81.6 million in the fourth quarter.

Find out more about Dendreon including full access to the free equity report at: www.BedfordReport.com/DNDN

Inovio Pharmaceuticals, Inc. (NYSE: INO) shares spiked 17 percent on more than three times the average daily volume Monday. The company and the PATH Malaria Vaccine Initiative (MVI) have agreed to a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.

Find out more about Inovio Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/INO

Molycorp Inc. (NYSE: MCP) shares gained 12 percent on more than double the average daily volume Monday. The company has been a prime takeover target for major companies who are looking to lock-up a steady source of rare-earth resources.

Find out more about Molycorp including full access to the free equity report at: www.BedfordReport.com/MCP

Peregrine Pharmaceuticals (NASDAQ: PPHM) shares soared nearly 80 percent on 56.5 million shares traded Monday. The company reported that they have found major discrepancies related to a mid-stage trial of their experimental cancer drug bavituximab.

Find out more about Peregrine Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/PPHM

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.